Pulmocide Limited

Matthew Stephen Coates

Stuart Thomas Onions

Kazuhiro Ito

Peter Strong

Euan Alexander Fraser Fordyce

Vladimir Sherbukhin

Daniel William Brookes

Simon Fraser Hunt

Peter John Murray

John King-Underwood

Jennifer Claire Thomas

There are provided 5,6-dihydro-4H-dithieno[3,2-b:2',3&#x2032;-d]azepine derivatives(as defined in the disclosure) which are useful in the treatment of RSV infection and for the prevention of disease associated with RSV infection.

Compounds

There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (I)). 

5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative

There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)). 

There are provided 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives which are useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. 

5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives

There are provided inter alia compounds which are intended to treat or prevent respiratory syncytial virus infections and associated disease particularly infections caused by the A and B strains thereof.

Growing community of inventors

London, United Kingdom

Matthew Stephen Coates